Under contract with Peter Doherty Institute, NRL assessed the performance of 12 rapid diagnostic tests listed in the Australian Registry of Therapeutic Goods by the Therapeutic Goods Administration.

NRL also provided fee for service agreements with manufacturers for similar assessments of SARS-CoV-2 serology test kits using an established protocol.

The table below represents a summary of the independent NRL contracted SARS-CoV-2 IVD assessments.


  • Evaluated test kits in the TGA assessment: PDI/TGA
  • Independent manufacturer evaluated test kits: MAN